Loading company…
NKGEN researches cancer immunotherapies and develops immune cell therapies and related products.
Founded in 2016 in South Korea, NKGEN focuses on cancer immunotherapy research and product development. Its activities include immune cell therapies, specialized culture media for those therapies and cell storage.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in